Latest filing published 17 May 2006 for CardioVascular BioTherapeutics, Inc., €49k.
Insider track record
No signal scores available.
Paladin Capital Management: trading record in brief
Paladin Capital Management is a declared insider of CardioVascular BioTherapeutics, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 17 April 2006 to 17 May 2006.
Every open-market trade on record is a sale: 3 sales worth €158k.
The latest filing, published on 17 May 2006, reports an open-market sale of €49k in CardioVascular BioTherapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paladin Capital Management
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$6.25commonSEC:0001273589-06-000004:0
- 10,000 shares@ US$5.95commonSEC:0001273589-06-000003:0
- 10,000 shares@ US$7.82commonSEC:0001360039-06-000001:0
3 of 3 declarations